Our therapy areas
Pioneering T cell receptor innovation
Immunocore is a leading T Cell Receptor (TCR) biotechnology company focused on delivering first-in-class biological therapies that will have the potential to address unmet needs in cancer, infectious and autoimmune diseases.
Immunocore has a robust clinical-stage pipeline of wholly-owned and partnered programmes across three different therapeutic areas:
Oncology
Molecules in development
ImmTAC (Immune Mobilizing Monoclonal TCRs Against Cancer) molecules
Infectious Diseases
Molecules in development
ImmTAV and ImmTAB (Immune Mobilizing Monoclonal TCRs Against Virus or Bacteria) molecule
Autoimmune and Inflammation diseases
Molecules in development
ImmTAAI (Immune Mobilizing Monoclonal TCRs Against Autoimmune Disease) molecule